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ABSTRACT
We hypothesized that bone resorption acts to increase bone strength through stimulation of periosteal expansion. Hence, we
examined whether bone resorption, as reﬂected by serum b‐C‐telopeptides of type I collagen (CTX), is positively associated with
periosteal circumference (PC), in contrast to inverse associations with parameters related to bone remodeling such as cortical bone
mineral density (BMDC). CTX and mid‐tibial peripheral quantitative computed tomography (pQCT) scans were available in 1130
adolescents (mean age 15.5 years) from the Avon Longitudinal Study of Parents and Children (ALSPAC). Analyses were adjusted for
age, gender, time of sampling, tanner stage, lean mass, fat mass, and height. CTX was positively related to PC (b¼ 0.19 [0.13, 0.24])
(coefﬁcient¼ SD change per SD increase in CTX, 95% conﬁdence interval)] but inversely associated with BMDC (b¼ –0.46 [–0.52,–
0.40]) and cortical thickness [b¼ –0.11 (–0.18, –0.03)]. CTX was positively related to bone strength as reﬂected by the strength‐strain
index (SSI) (b¼ 0.09 [0.03, 0.14]). To examine the causal nature of this relationship, we then analyzed whether single‐nucleotide
polymorphisms (SNPs) within key osteoclast regulatory genes, known to reduce areal/cortical BMD, conversely increase PC. Fifteen
such genetic variants within or proximal to genes encoding receptor activator of NF‐kB (RANK), RANK ligand (RANKL), and
osteoprotegerin (OPG) were identiﬁed by literature search. Six of the 15 alleles that were inversely related to BMD were positively
related to CTX (p< 0.05 cut‐off) (n¼ 2379). Subsequently, we performed a meta‐analysis of associations between these SNPs and PC
in ALSPAC (n¼ 3382), Gothenburg Osteoporosis and Obesity Determinants (GOOD) (n¼ 938), and the Young Finns Study (YFS)
(n¼ 1558). Five of the 15 alleles that were inversely related to BMD were positively related to PC (p< 0.05 cut‐off). We conclude that
despite having lower BMD, individuals with a genetic predisposition to higher bone resorption have greater bone size, suggesting
that higher bone resorption is permissive for greater periosteal expansion. © 2014 The Authors. Journal of Bone and Mineral Research
published by Wiley Periodicals, Inc. on behalf of the American Society for Bone and Mineral Research. This is an open access article
under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
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Introduction
Bone size and geometrymake amajor contribution to fracturerisk, reﬂecting the fact that bending strength of bone is
critically dependent on its diameter.(1) Consistent with this view,
we previously found that bone size relative to body size is a
stronger protective factor against fractures in children compared
with bone mineral density (BMD) measurements alone.(2)
Increases in bone diameter, accomplished through periosteal
expansion, largely occur in childhood as part of the process of
bone modeling. Gender differences in periosteal expansion (for
example, in expansion of hip circumference during puberty(3))
may help to explain the higher prevalence of hip fractures in
women compared with men in later life. Periosteal expansion is
also thought to continue after longitudinal growth has ceased,
although this subsequently declines in later life, limiting its ability
to compensate for the higher resorption and endocortical
expansion that characterizes bone loss in the elderly.(4) This
process may potentially protect from bone loss during aging.
However, in spite of the importance of periosteal expansion to
bone strength and fracture risk, this process has largely been
ignored as a possible drug target, and we remain ignorant of
many of the factors that inﬂuence it.(5)
One factor that may play a largely unrecognized role in
periosteal expansion is bone resorption. As well as a role in bone
remodeling, resorption is involved in growth and modeling, as
evidenced by observations that periods of rapid growth such as
puberty are associated with marked increases in resorption as
well as formation markers.(6) Remodeling is thought to be
initiated by bone resorption, with bone formation occurring at
sites of previous resorption.(7) In contrast, increased resorption
during growth is generally held to be secondary to increased
bone formation. For example, resorption of the primary and
secondary spongiosa occurs during endochondral bone forma-
tion at the growth plate, and resorption of cortical bone is
required for adaptation of cortical bone shape and geometry to
mechanical loading. However, it is not inconceivable that bone
resorption plays a primary role in modeling as well as
remodeling, such that periosteal expansion occurs secondary
to increased resorption. For example, osteoclastic bone resorp-
tion also takes place at the periosteum.(4) Moreover, it has been
proposed that periosteal expansion represents part of an overall
response intended to retain bone strength in the face of
endosteal expansion.(4)
In the present study, we aimed to examine the contribution of
bone resorption to periosteal expansion. We performed a cross‐
sectional analysis of associations between b‐C‐telopeptides of
type I collagen (CTX) and measures obtained from mid‐tibial
peripheral quantitative computed tomography (pQCT) scans in a
large group of adolescents from the Avon Longitudinal Study of
Parents and Children (ALSPAC). Because bone modeling
contributes a higher proportion to overall CTX levels in children
compared with adults, this age group is ideally suited to
analyzing relationships between resorption markers and phe-
notypes related to bone modeling. We aimed to determine
whether CTX is positively associated with bone size as reﬂected
by periosteal circumference (PC), in contrast to inverse
associations with phenotypes such as cortical bone mineral
density (BMDC) related to bone remodeling. Furthermore, we
aimed to establish whether any positive association between
CTX and PC reﬂects a causal pathway between bone resorption
and periosteal expansion, by analyzing whether single‐nucleo-
tide polymorphisms (SNPs) related to receptor activator of NF‐kB
(RANK), RANK ligand (RANKL), and/or osteoprotegerin (OPG)
presumed to increase bone resorption are also associated with
greater PC.
Materials and Methods
ALSPAC is a geographically based UK cohort that recruited
pregnant women residing in Avon (southwest England) with an
expected date of delivery between April 1, 1991, and Decem-
ber 31, 1992. A total of 15,247 pregnancies were enrolled with
14,775 children born (see www.alspac.bris.ac.uk for more
information).(8,9) Of these births, 14,701 children were alive at
12 months. The present study is based on research clinics to
which thewhole cohort was invited, heldwhen participants were
mean ages of 15.5 years. Ethical approval was obtained from the
ALSPAC Law and Ethics committee, and the Local Research Ethics
Committees. Parental consent and child’s assent was obtained
for all measurements made.
Tibial pQCT
BMDC and cortical bone mineral content (BMCC) of the mid (50%
from the distal endplate) right tibia were obtained using a Stratec
XCT2000L (Stratec, Pforzheim, Germany) during the age 15.5‐
year research clinic to which all ALSPAC participants were invited
as part of a study investigating the effects of physical activity on
cortical bone as previously published.(10) PC, endosteal circum-
ference (EC), and cortical thickness (CT) were derived using a
circular ring model. Cortical bone was deﬁned using a threshold
above 650mg/cm3,(10) and BMDC subsequently derived.
Strength strain index (SSI) was calculated according to the
formula published by Hasegawa and colleagues.(11)
Other variables
Height was measured using a Harpenden stadiometer (Holtain
Ltd., Crymych, UK), and weight was measured to the nearest 50 g
using Tanita weighing scales (Tanita UK Ltd., Uxbridge, UK). Data
on lean mass and fat mass were obtained from total body dual‐
energy X‐ray absorptiometry (DXA) scans performed at the age
15.5‐year clinic, using a Lunar Prodigy scanner (Lunar Radiation
Corp., Madison, WI, USA) with pediatric scanning software (GE
Healthcare Bio‐Sciences Corp., Piscataway, NJ, USA). Information
on skeletal maturity was based on results of Tanner stage
questionnaire at age 13.5 years (pubic hair domain), as previously
found to be related to hip development as assessed by DXA.(3)
Electrochemiluminescence immunoassays (ECLIA) (Roche Diag-
nostics, Lewes, UK) were used tomeasure plasma concentrations
of CTX on fasting samples collected at the age 15.5‐year clinic
visit (detection limit 0.01 ng/mL), plasma being separated and
frozen within 4 hours at –80°C. Inter‐ and intra‐assay coefﬁcients
of variation (CVs) were <6.0% across the working range.
Genetic studies of periosteal circumference
We recently reported results for a genome‐wide meta‐analysis
study for pQCT‐derived BMDC involving three discovery cohorts,
namely ALSPAC (n¼ 3382), The Gothenburg Osteoporosis and
Obesity Determinants (GOOD) (n¼ 938), and Young Finns (YFS)
(n¼ 1558).(12) As part of the same study, a genome‐wide
association study (GWAS) was also performed for PC, including
age, gender, height, and weight (ln) as covariates, using additive
linear regression in MACH2QTL for ALSPAC, ProbABEL(13) for YFS,
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and MACH2QTL on GRIMP(14) for the GOOD analyses. A meta‐
analysis of the results from the three cohorts was then performed
using the inverse variance method in METAL.(15) Standardized
betas and standard errors from each study were combined using
a ﬁxed effect model, which weights the studies using the inverse
variance and applying genomic control to individual studies and
the combined results. No associations were observed reaching
genome‐wide signiﬁcance (p< 5 108) (data not shown). Here,
we compiled a list of SNPs related to RANK, RANKL, and OPG
previously found to be associated with lumbar and/or hip areal
BMD at a genome‐wide signiﬁcance level, and looked up their
association with PC, CT, and BMDC in these three cohorts
individually and after meta‐analysis (a RANKL SNP previously
identiﬁed as being associated with BMDC was also included
(16)).
We also looked up associations of these SNPs with CTX results in
ALSPAC, based on the same model (with additional adjustment
for time drawn). A description of GOOD and YFS participants
included in this study and how pQCT and genetic data were
collected are provided in the Supplemental Materials. {Suppl
materials}
Statistical analysis
Descriptive statistics are presented as means, standard devia-
tions, and interquartile cut‐points. EC was adjusted for PC (ECPC)
to derive a measure of relative cortical thickness. Ordinary least
squares (OLS) linear regression was used to investigate: i) the
relationship between known factors that inﬂuence the variation
in serum concentrations of CTX; ii) the associations between CTX
and pQCT variables after adjustment for average age (calculated
from the age at scan and the age serumwas drawn), time of clinic
attendance (whether participants attended a morning or
afternoon clinic, to take account of diurnal variation in CTX
[samples largely clustered to within an hour of 8 a.m. or 12 p.m.]),
gender, and Tanner stage (model 1); and iii) the effect of further
adjustment for lean mass, fat mass, and height on model 1 (ie,
model 2) (fat and lean mass were adjusted for in preference to
weight, to account for the distinct relationship of these two
compartments with cortical bone parameters).(10) Because of the
inverse association between BMDC and PC, which we previously
reported,(10) results were also analyzed where BMDC was
adjusted for PC. Gender differences were explored by comparing
b coefﬁcients between separate analyses in males and females
and by testing for gender interactions in analyses performed in
males and females combined. A similar approach was used to
examine the relationship between quartiles of CTX and the
above‐mentioned pQCT measures, using the fully adjusted
model (model 2). All analyses were conducted in STATA 11.1 MP
(StataCorp, College Station, TX, USA).
Results
Description of participants
A total of 1130 participants (487 males, 643 females) were
identiﬁed in ALSPAC with serummeasurements of CTX and valid
pQCT data at age 15.5 years. Height, weight, lean mass, and CTX
were greater in males in contrast to fat mass, which was
substantially greater in female participants (Table 1). BAC, BMCC,
CT, PC, and SSI were greater in male participants, whereas BMDC
and ECPC were higher in females.
Associations between CTX and confounders
Age, gender, time of sampling, and Tanner stage all showed
strong inverse associations with CTX (Supplemental Table S1,
model 1). When height and weight were added, positive and
inverse associations with CTX were observed, respectively.
Weight was subsequently replaced by fat and lean mass, both
of which showed independent inverse associations with CTX,
although overall model ﬁt was unchanged (Akaike information
Table 1. Characteristics of Participants Included in the Analysis of CTX and Tibial pQCT‐Derived Parameters as Mean, SD, Median, 25th
(p25), and 75th (p75) Centiles
pQCT Variable Male Mean SD p25 Median p75 Female Mean SD p25 Median p75
Age (years) 15.43 0.24 15.29 15.38 15.51 15.45 0.25 15.30 15.41 15.55
Height (cm) 173.91 6.97 169.30 174.40 178.70 164.62 5.82 161.10 164.40 168.30
F‐mass (kg) 10.04 6.78 5.72 8.14 11.95 17.65 6.58 13.04 16.44 21.46
L‐mass (kg) 49.54 6.19 45.53 49.46 53.82 37.01 3.66 34.68 36.75 39.46
Weight (kg) 62.39 10.00 56.20 61.50 67.50 57.70 8.73 51.90 56.60 62.80
CTX (ng/mL) 1.51 0.52 1.14 1.43 1.84 0.72 0.25 0.54 0.68 0.85
BAc (cm2) 328.75 42.74 298.75 329.54 356.72 275.23 34.90 252.93 273.98 297.15
BMCc (mg) 353.53 48.86 319.97 352.04 384.76 309.78 39.53 283.68 307.32 334.96
BMDc (mg/cm3) 1074.69 33.67 1055.56 1077.66 1097.27 1125.61 22.11 1111.37 1126.92 1140.16
BMDc‐adj‐PC (mg/cm3) 1084.51 35.75 1063.39 1088.20 1108.73 1116.55 22.74 1103.08 1117.68 1133.01
CT (mm) 5.62 0.62 5.21 5.63 6.02 5.20 0.54 4.82 5.21 5.56
EC (mm) 40.96 5.48 37.26 40.73 44.10 36.71 5.03 33.49 36.15 39.47
EC‐adj‐PC (mm) 38.44 3.81 36.02 38.37 40.65 38.91 3.32 36.76 38.78 40.98
PC (mm) 76.25 5.04 73.12 76.03 79.52 69.35 4.69 66.20 68.96 72.37
SSI (mm3) 1159.41 219.24 1005.68 1149.89 1301.66 918.48 172.95 801.30 895.20 1031.73
Age¼mean age between age at pQCT scan and age when the blood sample was taken; CTX¼b‐C‐telopeptides of type I collagen; F‐mass¼ total body
fat mass; L‐mass¼ total body lean mass; BAc¼ cortical bone area; BMCC¼ cortical bone mineral content; BMDC¼ cortical bone mineral density;
PC¼periosteal circumference; CT¼ cortical thickness; EC¼ endosteal circumference; BMDC‐adj‐PC¼ cortical bone mineral content adjusted for
periosteal circumference; EC‐adj‐PC¼ endosteal circumference adjusted for periosteal circumference; SSI¼ strength strain index.
Breakdown of participants according to Tanner stage and gender (male/female) at age 13.5 years: stage 1 (n¼ 49/30); stage 2 (n¼ 126/74); stage 3
(n¼ 135/145); stage 4 (n¼ 147/260); and stage 5 (n¼ 30/134).
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criterion¼ 2412, 2368, and 2369 formodel 1, model 1 plus height
and weight, and model 2, respectively).
CTX versus tibial pQCT variables
In our minimally adjustedmodel (ie, model 1), CTX was unrelated
to overall bone size as reﬂected by PC, but a strong positive
association was observed after adjustment for body composition
(ie, model 2 [Table 2]). Conversely, CTX appeared to be related to
cortical thinning and increased cortical remodeling, as reﬂected
by inverse associations with CT and BMDC, and a positive
association with ECPC. CTX showed similar relationships with
BMDC and ECPC in both models, whereas the association with CT
showed partial attenuation after adjustment for body composi-
tion, as reﬂected by a 50% decrease in beta coefﬁcients in model
2 versus model 1. Despite opposite relationships with PC and CT,
there was a net positive association between CTX and BAC and
SSI (model 2). We also examined the relationship between CTX
and pQCT measures by analyzing the latter variables, adjusted
according to model 2, according to CTX quartile. Successive
quartiles of CTX were associated with a linear increase in both PC
and SSI (Fig. 1). Conversely, there was a progressive decline in
BMDC, in which change was most marked for the top quartile.
Increasing quartiles of CTX were also associated with a linear
increase in ECPC. Throughout, similar results were obtained in
males and females, as indicated by p> 0.1 for gender interaction.
Exploration of causal pathways
Selection of genetic instruments for bone resorption
We hypothesized that the positive association between CTX and
PC reﬂects a causal pathway whereby increased bone resorption
leads to an increase in periosteal expansion (Fig. 2). We explored
this question using a Mendelian Randomization approach,(17)
based on genetic instruments that reﬂect constitutive determi-
nants of bone resorption. To our knowledge, no genetic markers
have been robustly associated with either CTX or any other
resorption marker. Therefore, we adopted an alternative strategy
using SNPs within and immediately adjacent to the genes for
RANK, RANKL, and OPG, which have previously been reported to
be associated with areal/cortical BMD in genome‐wide meta‐
analysis, on the assumption that these associations are likely to
be mediated by genetic effects on bone resorption. Seven OPG,
four RANKL, and two RANK gene SNPs (including SNPs
immediately adjacent to these genes) were identiﬁed as being
associated with lumbar spine and/or femoral neck areal BMD
from genome‐wide meta‐analyses(18–22) (Table 3). One further
independent OPG SNP (ie, rs7839059) and one further indepen-
dent RANKL SNP (ie, rs1021188) were included on the basis of
previous reported association with BMDC.
(16)
Genetic association studies in ALSPAC
We investigated whether associations between the 15 RANK,
RANKL, and OPG SNPs and areal/cortical BMD, described in
Table 3, are likely to be mediated by genetic effects acting to
increase bone resorption. Six of these 15 alleles were related to
CTX in the opposite direction to areal/cortical BMD (rs7839059
[OPG], rs9533090, rs9594738, rs1021188 [RANKL], rs884205,
rs3018362 [RANK]), based on a p< 0.05 cut‐off for nominal
signiﬁcance (Table 3). Subsequently, we analyzed associations
between RANK/RANKL/OPG SNPs and pQCT parameters. Five of
the 15 RANK/RANKL/OPG SNPs were related to CT, the risk alleles
being the same as those for areal/cortical BMD in all cases
(Supplemental Table S2). Similarly, 9 of the 13 SNPs previously
reported to be associated with areal BMD were also related to
BMDC, with equivalent risk alleles for each trait (Supplemental
Table S3).
We then explored a possible causal pathway between bone
resorption and periosteal expansion by examining whether
RANK/RANKL/OPG SNPs associated with areal/cortical BMD are
also associated with PC. In particular, we wished to determine
whether alleles that are inversely related to BMD (indicating
greater bone resorption) are positively related to PC. Interest-
ingly, three of these RANK/RANKL/OPG SNPs were associated
with PC (p< 0.05), the direction of effect being opposite to that
observed for areal/cortical BMD in all instances (Supplemental
Table S4).
Table 2. Regression Analyses of CTX versus pQCT Variables in 1130 Participants Aged 15.5 Years (487 Males, 643 Females)
Outcome Model 1 Model 2
b SE L_CI U_CI p Value b SE L_CI U_CI p Value
BAc –0.12 0.036 –0.19 –0.05 1.08 103 0.06 0.026 0.01 0.12 1.50 102
BMCC –0.22 0.038 –0.30 –0.15 <0.001 –0.03 0.028 –0.09 0.02 2.48 101
BMDC –0.45 0.028 –0.51 –0.39 <0.001 –0.46 0.029 –0.52 –0.40 <0.001
BMDC‐adj‐PC –0.49 0.032 –0.56 –0.43 <0.001 –0.42 0.031 –0.48 –0.36 <0.001
CT –0.24 0.040 –0.32 0.16 <0.001 –0.11 0.037 –0.18 –0.03 4.27 103
EC 0.20 0.045 0.12 0.29 <0.001 0.29 0.043 0.20 0.37 <0.001
EC‐adj‐PC 0.28 0.045 0.20 0.37 <0.001 0.22 0.045 0.13 0.31 <0.001
PC 0.02 0.038 –0.05 0.09 6.07 101 0.19 0.029 0.13 0.24 <0.001
SSI –0.10 0.038 –0.18 –0.03 8.51 103 0.09 0.027 0.03 0.14 1.32 103
Model 1¼ adjustment for age, gender, whether the individual attended the clinic in the morning or afternoon, and Tanner stage. Model 2¼Model 1 in
addition to lean mass, fat mass, and height.
SE¼ standard error; b¼ SD change in outcome per SD increase in CTX; L_CI¼ lower 95% conﬁdence estimate of b; U_CI¼ upper 95% conﬁdence
estimate of b; p¼ strength of evidence against the null hypothesis of no association between the outcome and exposure variable; BAC¼ cortical bone
area; BMCC¼ cortical bone mineral content; BMDC¼ cortical bone mineral density; PC¼periosteal circumference; CT¼ cortical thickness; EC¼ endosteal
circumference; BMDC‐adj‐PC¼ cortical bone mineral content adjusted for periosteal circumference; EC‐adj‐PC¼ endosteal circumference adjusted for
periosteal circumference; SSI¼ strength strain index.
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Similar ﬁndings were obtained based on allele scores
generated without prior knowledge of the individual SNP tests.
These scores were constructed using allele counts from top hits
within the three loci as reported by Estrada and colleagues.(19)
The three SNPs selected are highlighted in bold (Table 3), along
with rs1021188, which was also selected on the basis that this
SNP represents a further independent genetic inﬂuence. An
increase in CTX (b¼ 0.07 [0.05, 0.10] and p¼ 5.3 108),
decrease in BMDC (b¼ –0.09 [–0.11, –0.06] and p¼ 1.5 1011),
decrease in CT (b¼ –0.05 [–0.07, –0.02] and p¼ 0.002), and
increase in PC (b¼ 0.03 [0.01, 0.05] and p¼ 0.01] were observed
per unit increase in areal/cortical BMD risk allele score. After
exclusion of rs2062377 from generation of allele scores, on the
basis that this was unrelated to CTX, similar results were
obtained: each unit increase in risk allele score was associated
with an increase in CTX (b¼ 0.07 [0.05, 0.10] and p¼ 4.1 108],
decrease in BMDC (b¼ –0.07 [–0.10, –0.05] and p¼ 5.4 109),
decrease in CT (b¼ –0.04 [–0.07, –0.01] and p¼ 0.01), and
increase in PC (b¼ 0.02 [0.002, 0.04] and p¼ 0.03).
Replication studies in other cohorts
We looked up associations between the 15 RANK/RANKL/
OPG SNPs related to areal/cortical BMD and pQCT traits from
Fig. 1. Relationships between quartiles of CTX and cortical BMD (A), periosteal circumference (B), endosteal circumference adjusted for periosteal
circumference (C), and strength strain index (D). Data show mean > SD of each trait for each quartile of CTX at age 15 years, adjusted for average age,
gender, Tanner stage, timing of sample collection, lean mass, fat mass, and height in 1130 individuals (boys¼ 487, girls¼ 643). p¼ strength of evidence
against the null hypothesis of no association between the outcome and exposure variable.
Fig. 2. Proposed causal pathway between bone resorption and
periosteal circumference. Solid arrows depict relationships assumed a
priori. Two‐headed arrow represents the observed association between
CTX and periosteal circumference. Dashed arrow represents the
hypothetical causal pathway between bone resorption and periosteal
circumference to be explored.
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our GWAS involving two other cohorts, namely GOOD and
YFS. In YFS, all 8 OPG SNPs showed an equivalent relationship
with CT to that observed for areal/cortical BMD (Supplemental
Table S2); 9 of the 13 SNPs associated with areal BMD
showed equivalent relationships with BMDC (Supplemental
Table S3); 9 of the 15 areal/cortical BMD SNPs showed
opposite associations with PC (Supplemental Table S4). Equiva-
lent ﬁndings were observed in GOOD in respect of BMDC
associations, whereas there was less evidence for associations
with CT and PC.
Finally, we performed ameta‐analysis of associations between
the 15 RANK/RANKL/OPG SNPs and pQCT parameters across all
three cohorts. Nine of these SNPs were associated with CT
(Table 4). Of the 13 SNPs previously identiﬁed as being associated
with areal BMD, 11 were also associated with BMDC. These
associations were stronger for BMDc than for CT. The risk allele
was equivalent when comparing areal BMD with BMDC/CT in all
instances apart from rs9533093, which was unique in being
associated with CT but not BMDC and may have represented a
false positive. Five of the 15 alleles related to areal/cortical BMD
were associated with PC, the direction of effect being opposite to
that for BMD in all cases (rs4355801, rs2062375 [OPG]; rs884205,
rs3018362 [RANK], rs1021188 [RANKL]) (p< 0.05) (Table 4). Three
further alleles showed evidence of a weak association with PC in
the opposite direction to areal and cortical BMD (rs7839059,
rs2062377, rs6469804 [OPG]) (p< 0.1).
Discussion
In a large cohort of adolescents, we found CTX to be positively
related to periosteal expansion as reﬂected by PC but inversely
related to BMDC and CT. The associations between CTX and PC
and BMDC were particularly striking, such that a one‐SD increase
in CTX was associated with 0.19 and 0.46 SD changes in these
parameters, respectively. In spite of the ﬁnding that higher CTX
was related to lower CT, the positive relationship between CTX
and PC translated into a positive relationship with BAC. A positive
relationship was also observed between CTX and predicted bone
strength as estimated by SSI, reﬂecting the fact that the latter
parameter is strongly inﬂuenced by bone size. Although SSI is
also determined by BMDC, the inverse relationship between CTX
and BMDC did not appear to be sufﬁcient to offset the positive
relationship between CTX and SSI.
The positive association between CTX and bone area and PC
was only evident after adjusting for body size, reﬂecting a
separate inverse association between CTX and bone size acting
via weight. The latter pathway reﬂects two distinct components.
We have previously reported positive associations between fat
and lean mass, and bone area and PC as measured by DXA and
pQCT respectively.(10,23) Furthermore, there appeared to be an
inverse association between CTX and fat and lean mass,
consistent with previous reports of an inverse association
between fat mass and another turnover marker, osteocalcin.(24)
Although we are not aware of equivalent reports of associations
of CTX with lean mass, possibly this relationship reﬂects the
pathway between bone turnover and energy balance previously
suggested by Karsenty and colleagues, thought to be mediated
by osteocalcin.(25,26)
To explore the causal nature of the association between CTX
and PC, we applied an instrumental variable approach, as
previously used to examine the relationship between fat mass
and bone mass.(27) Although bone resorption was evaluated by
measurement of plasma CTX, to our knowledge, no genetic
markers for CTX are available. Therefore, we selected genetic
instruments on the basis of i) known biological role in bone
metabolism restricted to bone resorption, and ii) established
association with areal/cortical BMD. RANKL/RANK/OPG was
ideally suited for this purpose; this pathway plays a major role
in regulating osteoclast differentiation, to which its biological
effects are restricted as evidenced by extensive animal and
clinical data;(28,29) SNPs related to RANKL/RANK/OPG are not only
robustly associated with areal BMD, but also this is one of the
three key pathways found to explain genetic variability of this
trait.(19) Consistent with the suggestion that SNPs related to
RANKL/RANK/OPG can be used as genetic instruments for bone
resorption, the rs1021188 RANKL SNP has previously been
related to RANKL expression(23) and to cortical porosity as
measured by high‐resolution peripheral quantitative computed
tomography (HR‐pQCT).(13) Moreover, in the present study, a
large proportion of RANK/RANKL/OPG SNPs showed equivalent
associations with CTX levels, BMDC, and CT to those seen for areal
BMD. Even in the case of those RANK/RANKL/OPG SNPs that
showed little evidence of association with CTX, we assume that
their association with BMD is mediated by altered levels of bone
resorption, given that the role of the RANK/RANKL/OPG system is
restricted to regulation of osteoclast function.
Therefore, our observation that a substantial proportion of
these SNPs are also related to PC, such that a risk allele for areal/
cortical BMD is associated with greater PC, raises the possibility
that a causal pathway exists between increased bone resorption
and greater periosteal expansion. Areal BMD, which was used to
identify 13 of our 15 genetic instruments, is positively associated
with traits such as PC, which reﬂect bone size.(30) Therefore, any
phenotypic correlation between areal BMD and PC is unlikely to
provide an alternative explanation for our ﬁndings because this
would result in genetic markers of lower areal BMD having a
lower PC, in contrast to a higher PC as reported here. On the
other hand, we previously reported an inverse association
between BMDC and PC,
(10) which may help to explain why the
two SNPs (rs1021188 and rs7839059) associated with lower
BMDCwere associatedwith higher PC. This ismademore likely by
the fact that these two SNPs were originally identiﬁed in a meta‐
analysis based on the same cohorts used to examine associations
with PC. However, BMDC is strongly inﬂuenced by cortical
porosity, which in turn reﬂects bone remodeling, consistent with
the strong inverse relationship we observed between BMDC and
CTX. Therefore, rather than providing a spurious association, the
phenotypic correlation between BMDC and PC is likely to be a
direct consequence of our hypothesized causal pathway
between bone resorption and periosteal expansion.
Taken together, our results suggest that although individuals
with a constitutive predisposition to higher rates of bone
resorption have a lower areal and/or cortical BMD, any adverse
effect on bone strength and fracture risk may be at least partially
compensated for by greater bone size. One possible mechanistic
explanation for this relationship is that periosteal expansion
occurs as a compensatory response to increased endosteal
expansion as part of the mechanostat, thereby serving to
maintain strains within cortical bone within a target range.(31)
However, if this explanation was responsible, one might have
expected that CTX would have no net association with BAC or SSI
once compensatory changes in PC are taken into account, in
contrast to the positive associations, which we observed with
these parameters. Although the associations between CTX and
bone size relative to body size that we report are limited to
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adolescents, our genetic study encompassed older individuals
and raise the possibility that positive relationships between CTX
and bone size persist into later life. Consistent with this
suggestion, if anything, associations between RANK/RANKL/
OPG SNPs and PC were strongest in YFS, which comprises adults
aged 31 to 46 years.
Any tendency for higher bone resorption to be permissive for
greater bone expansionmay have implications for bone strength
and fracture risk. For example, in a previous prospective study,
we found that bone size relative to body size is an important
protective factor for fracture risk in childhood.(2) Higher rates of
bone resorption in childhood may also protect against fracture
risk in later life as a consequence of effects on bone size. For
example, higher rates of bone resorption in boys compared with
girls during puberty and adolescence, as noted here and
previously,(32,33) may contribute to the greater periosteal
expansion of the hip that occurs at this time in boys compared
with girls;(3) this may in turn contribute to the lower fracture risk
of males compared with females in later life. Similarly, reports
that CTX is reduced in children and adolescents with type I
diabetes(34) suggest that reduced modeling contributes to the
increased risk of hip fractures seen in this condition in later life.(35)
Limitations
Our cross‐sectional study in ALSPACwas limited in that CTX is the
only bone turnover marker measured in this cohort to date.
Because formation and resorption markers are both produced
during growth, modeling, and remodeling, equivalent results are
likely to have been obtained based on bone formation markers
that are also produced as part of these processes. Because CTX is
a marker of type I collagen, which is not restricted to bone, it
would also have been preferable to conﬁrm our ﬁndings based
on another resorption marker. A further limitation is that this
study was based on a subset of the original ALSPAC cohort and is
therefore likely to differ from a truly representative population
sample in several ways. We ran furthermodels adjusting for other
confounders such as physical activity, based on contemporane-
ous accelerometer recordings, which did notmaterially affect the
results (data available on request). However, we were unable to
adjust for other potential confounders that were not measured,
such as contemporaneous levels of 25‐hydroxyvitamin D3. In
terms of limitations to our genetic analyses, although SNPs
related to RANK/RANKL/OPG were used as genetic instruments
for bone resorption, we are unable to exclude the possibility that
these SNPs may have inﬂuenced BMD via other pathways. Few
alternative genetic instruments for bone resorption exist to
enable conﬁrmation of our ﬁndings based on other pathways.
Rs13336428, which is related to the CLCN7 gene for the
osteoclast chloride channel required for bone resorption, was
reported to be associatedwith areal BMD,(19) but we observed no
association between this SNP and CTX in ALSPAC (data available
on request).
Having investigated associations between CTX and pQCT
measurements from themid‐tibia in adolescents aged 15.5 years,
bone resorption was found to be inversely related to traits
reﬂecting lower rates of bone remodeling such as BMDC but
positively related to traits reﬂecting greater bone modeling such
as PC. It is well established that bone resorption is the primary
determinant of bone remodeling, but its relationship with bone
modeling, which we went on to explore using a genetics
approach, is less clear cut. Interestingly, genetic factors that
predispose to greater bone resorption were also found to
predispose to greater PC, raising the possibility that higher bone
resorption is permissive for greater periosteal expansion. In light
of these ﬁndings, further studies are justiﬁed to examinewhether
systemic markers of bone resorption might prove useful in
monitoring adverse effects of pharmacotherapy and disease
states on skeletal modeling, particularly during periods when
this process is most active, such as during childhood and
adolescence.
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